"In the past 100 years, there has been a revolution in our understanding of the brain. So far, this has done little to disrupt mainstream psychiatric practice. That is set to change. New neuroscience-based treatments are emerging, while evidence from neuroscience and genetics are calling into question traditional diagnostic boundaries. Psychiatrists of the future will need to integrate their understanding of brain imaging, molecular diagnostics, psychological factors and social context to provide neuroscience-informed care plans"--
"In the past 100 years, there has been a revolution in our understanding of the brain. So far, this has done little to disrupt mainstream psychiatric practice. That is set to change. New neuroscience-based treatments are emerging, while evidence from neuroscience and genetics are calling into question traditional diagnostic boundaries. Psychiatrists of the future will need to integrate their understanding of brain imaging, molecular diagnostics, psychological factors and social context to provide neuroscience-informed care plans"--Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
I. Cells: 1.1. Neurons 1.2. The physiology of neurons, synapses and receptors 1.3. Modelling single neurons and their combinations in circuits 1.4. Glia II. Neurotransmitters and Receptors: 2.1. The chemical synapse 2.2. Classification of receptors: metabotropic and ionotropic receptors 2.3. Neuronal receptors and drug targets 2.4. Basic pharmacology of specific neurotransmitter pathways 2.5. Neuropeptides 2.6. Genetic association studies and neurotransmitter pathways 2.7. Opioids and common recreational drugs III. Basic Techniques in Neuroscience: 3.1. Recording from the brain 3.2. Perturbing brain function 3.3. Animal models of psychiatric disease 3.4. Data analysis and computational modelling 3.5. Functional neuroimaging and connectivity IV. Neuroanatomy: 4.1. Fundamentals 4.2. The basal ganglia 4.3. The temporal lobes 4.4. The frontal lobes 4.5. White matter pathways 4.6. Ascending neurotransmitter systems V. Neural Circuits: 5.1. Appetite 5.2. Sleep 5.3. Sex and sex hormones 5.4. Violence and aggression 5.5. Nociception and pain 5.6. The motor system and movement disorders 5.7. Computational models of learning 5.8. Habit formation 5.9. Reward, pleasure and motivation 5.10. Emotion 5.11. Perception 5.12. Attention 5.13. Apathy, anhedonia and fatigue 5.14. Memory 5.15. Fronto-executive functions 5.16. Empathy and theory of mind 5.17. Language 5.18. Brain networks and dysconnectivity VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis 6.2. The stress response and glucocorticoids 6.3. Adrenal steroids 6.4. Inflammation and immune responses VII. Genetics: 7.1. Basic genetic principles and the history of gene identification 7.2. Common variation 7.3. Rare variation 7.4. Epigenetics 7.5. The clinical application of genetics in psychiatry VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function 8.2. Neurodevelopmental models of psychiatric disorders 8.3. Attachment 8.4. Neuroplasticity 8.5. Intelligence and intellectual disability IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism 9.2. Attention deficit hyperactivity disorder 9.3. Drug use, addiction, tolerance, withdrawal and relapse 9.4. Anxiety disorders 9.5. Post-traumatic stress disorder 9.6. Obsessive-compulsive and related disorders 9.7. Major depressive disorder 9.8. Bipolar affective disorder 9.9. Psychosis 9.10. Schizophrenia 9.11. Borderline personality disorder 9.12. Self-harm and suicidality 9.13. Medically unexplained symptoms 9.14. Delirium 9.15. Perinatal disorders 9.16. Sleep disorders 9.17. Eating disorders 9.18. Epilepsy and seizures 9.19. Electroconvulsive therapy 9.20. Brain stimulation X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality 10.2. Prodromal disease and mild cognitive impairment 10.3. Preclinical stages of neurodegenerative disease 10.4. Spectra, domains and dimensions of neurodegenerative disease 10.5. Reserve, resilience and resistance to neurodegeneration 10.6. Environmental causes of neurodegenerative disease 10.7. Morbidity and dual pathology in neurodegenerative disorders.
I. Cells: 1.1. Neurons 1.2. The physiology of neurons, synapses and receptors 1.3. Modelling single neurons and their combinations in circuits 1.4. Glia II. Neurotransmitters and Receptors: 2.1. The chemical synapse 2.2. Classification of receptors: metabotropic and ionotropic receptors 2.3. Neuronal receptors and drug targets 2.4. Basic pharmacology of specific neurotransmitter pathways 2.5. Neuropeptides 2.6. Genetic association studies and neurotransmitter pathways 2.7. Opioids and common recreational drugs III. Basic Techniques in Neuroscience: 3.1. Recording from the brain 3.2. Perturbing brain function 3.3. Animal models of psychiatric disease 3.4. Data analysis and computational modelling 3.5. Functional neuroimaging and connectivity IV. Neuroanatomy: 4.1. Fundamentals 4.2. The basal ganglia 4.3. The temporal lobes 4.4. The frontal lobes 4.5. White matter pathways 4.6. Ascending neurotransmitter systems V. Neural Circuits: 5.1. Appetite 5.2. Sleep 5.3. Sex and sex hormones 5.4. Violence and aggression 5.5. Nociception and pain 5.6. The motor system and movement disorders 5.7. Computational models of learning 5.8. Habit formation 5.9. Reward, pleasure and motivation 5.10. Emotion 5.11. Perception 5.12. Attention 5.13. Apathy, anhedonia and fatigue 5.14. Memory 5.15. Fronto-executive functions 5.16. Empathy and theory of mind 5.17. Language 5.18. Brain networks and dysconnectivity VI. Modulators: 6.1. The hypothalamic-pituitary (Neuroendocrine) axis 6.2. The stress response and glucocorticoids 6.3. Adrenal steroids 6.4. Inflammation and immune responses VII. Genetics: 7.1. Basic genetic principles and the history of gene identification 7.2. Common variation 7.3. Rare variation 7.4. Epigenetics 7.5. The clinical application of genetics in psychiatry VIII. Neurodevelopment and Neuroplasticity: 8.1. The development of brain structure and function 8.2. Neurodevelopmental models of psychiatric disorders 8.3. Attachment 8.4. Neuroplasticity 8.5. Intelligence and intellectual disability IX. Integrated Neurobiology of Specific Syndromes and Treatments: 9.1. Autism 9.2. Attention deficit hyperactivity disorder 9.3. Drug use, addiction, tolerance, withdrawal and relapse 9.4. Anxiety disorders 9.5. Post-traumatic stress disorder 9.6. Obsessive-compulsive and related disorders 9.7. Major depressive disorder 9.8. Bipolar affective disorder 9.9. Psychosis 9.10. Schizophrenia 9.11. Borderline personality disorder 9.12. Self-harm and suicidality 9.13. Medically unexplained symptoms 9.14. Delirium 9.15. Perinatal disorders 9.16. Sleep disorders 9.17. Eating disorders 9.18. Epilepsy and seizures 9.19. Electroconvulsive therapy 9.20. Brain stimulation X. Neurodegeneration: 10.1. A neurodegenerative cascade of causality 10.2. Prodromal disease and mild cognitive impairment 10.3. Preclinical stages of neurodegenerative disease 10.4. Spectra, domains and dimensions of neurodegenerative disease 10.5. Reserve, resilience and resistance to neurodegeneration 10.6. Environmental causes of neurodegenerative disease 10.7. Morbidity and dual pathology in neurodegenerative disorders.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
